Metabolic Dysfunction-Associated Steatotic Liver Disease in Chronic Hepatitis C Virus Infection: From Basics to Clinical and Nutritional Management
Open Access
- 24 November 2024
- journal article
- review article
- Published by MDPI AG in Clinics and Practice
- Vol. 14 (6) , 2542-2558
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely associated with obesity and other cardiometabolic risk factors. MASLD has rapidly become the most common cause of liver disease worldwide, currently affecting 38% of the global population. Excess weight causes chronic inflammation and the activation of different pathways involved in liver damage. MASLD can progress from simple steatosis to steatohepatitis, giving way to its inflammatory component, metabolic dysfunction-associated steatohepatitis (MASH), previously recognized as non-alcoholic steatosis hepatitis (NASH). Chronic hepatitis C virus (HCV) infection remains a significant challenge to liver health as it triggers hepatic inflammation, metabolic disruption, and hepatic steatosis. The convergence of MASLD and chronic HCV infection can significantly alter the course of liver disease and accelerate the progression to severe liver damage. Currently, HCV treatment has a high cure rate. However, in patients who achieve a sustained virological response after treatment with direct-acting antivirals, weight gain, and excessive calorie intake may contribute to increased liver steatosis and a higher risk of liver disease progression. Therefore, the effective clinical and nutritional management of HCV patients, both before and after viral eradication, is crucial to reducing the risk of death from hepatocellular carcinoma. Understanding the complex interactions between MASLD and HCV infection is crucial for managing these patients appropriately. Herein, host and viral mechanisms inducing liver damage during the coexistence of MASLD and HCV infection are described, and their therapeutic and dietary management are discussed.Keywords
Funding Information
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (CF-2023-I-1040)
This publication has 116 references indexed in Scilit:
- Whole-Exome Sequencing identified Olfactory Receptor genes as a key contributor to extreme obesity with progression to nonalcoholic steatohepatitis in Mexican patientsAnnals of Hepatology, 2022
- Effect of Omega‐3 Polyunsaturated Fatty Acids on Lipid Metabolism in Patients With Metabolic Syndrome and NAFLDHepatology Communications, 2022
- Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosisAdvanced Drug Delivery Reviews, 2021
- Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin‐Like Phospholipase Domain Containing 3–Mediated Acceleration of SteatohepatitisHepatology, 2021
- Inhibition of hepatitis C virus by vitamin D2021
- Advancements in genomic medicine and the need for updated regional clinical practice guidelines in the field of hepatologyAnnals of Hepatology, 2020
- Adiponectin Regulation and Function2011
- Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C†Hepatology, 2008
- The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype‐specific mechanisms†Hepatology, 2007
- Anti-HCV activities of selective polyunsaturated fatty acidsBiochemical and Biophysical Research Communications, 2004